VACONTIL Tablet Ref.[28044] Active ingredients: Loperamide

Source: Υπουργείο Υγείας (CY)  Revision Year: 2019  Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus

Product name and form

Vacontil 2 mg tablets.

Pharmaceutical Form


White, round, flat, scored tablets, embossed “V” with a diameter of 7mm.

Qualitative and quantitative composition

Each tablet contains loperamide hydrochloride 2 mg.

Excipient with known effect: lactose monohydrate and sodium.

For full list of excipients, see section 6.1.

Active Ingredient Description

By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.

List of Excipients

Lactose monohydrate
Microcrystalline cellulose
Croscarmellose sodium
Magnesium stearate

Pack sizes and marketing

Combination blisters of polyvinylchloride film and aluminium foil. Blisters with a patient information leaflet are inserted in a carton.

Cartons containing 10 or 20 tablets are available.

Cartons containing 40, 100, 500 or 1000 tablets are available.

Not all pack sizes may be marketed.

Marketing authorization holder

Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus

Marketing authorization dates and numbers


First authorisation date: 22.08.2011
Renewal date: 09/08/2016


Drug Countries
VACONTIL Cyprus, Hong Kong, Malta, Singapore

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.